Characterization of OP9 as authentic mesenchymal stem cell line

Area of Science:

• Stem Cell Biology
• Immunology
• Cell Biology

Background:

• Mesenchymal stem cells (MSCs) are crucial for regenerative medicine but challenging to expand in vitro.
• Mouse MSC expansion difficulties hinder in vivo research.
• The OP9 stromal cell line supports hematopoiesis.

Purpose of the Study:

• To characterize the OP9 cell line as a potential source of mouse mesenchymal stem cells (MSCs).
• To evaluate the immunophenotype, differentiation potential, immunomodulatory capacity, and migratory behavior of OP9 cells.

Main Methods:

• Immunophenotyping using flow cytometry for canonical MSC markers and perivascular cell markers.
• In vitro differentiation assays into osteocytes, chondrocytes, and adipocytes.
• Lymphocyte transformation test (LTT) and mixed leukocyte reaction (MLR) to assess immunomodulatory effects.
• Cell migration assays induced by various growth factors.

Main Results:

• OP9 cells displayed an immunophenotype identical to mouse MSCs (CD45(-), CD11b(-), FLK-1(-), CD31(-), CD34(-), CD44(+), CD29(+), Sca-1(+), CD86(-), MHCII(-)).
• Expression of CD140a, CD140b, alpha-SMA, and Calponin suggested a perivascular origin.
• OP9 cells showed strong clonogenic ability and could differentiate into osteocytes, chondrocytes, and adipocytes.
• OP9 cells suppressed T lymphocyte proliferation in LTT and MLR assays.
• OP9 cell migration was efficiently induced by bFGF, IGF-1, IL-3, PDGF-BB, TGF-beta1, and TGF-beta3.

Conclusions:

• The OP9 cell line represents bona fide mesenchymal stem cells (MSCs).
• This homogenous MSC line facilitates research into the fundamental biological properties of MSCs.
• OP9 cells offer a reliable model for studying MSC differentiation, immunomodulation, and migration.